Tus kws kho mob
QP83-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Kerendia®
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 27, 2021
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2051 - 2060 ntawm 3685
Tus kws kho mob
QP84-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Cholestasis Pruritis
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 27, 2021
Tus kws kho mob
Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Blocker (Corlanor) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2024
Tus kws kho mob
Hemophilia Factor IX - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2024
Tus kws kho mob
2021 November Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2021
Tus kws kho mob
Bariatric Surgery Commercial Pre-Authorization Request Form (Medical Policy IV-19) (PDF)
Tus kws kho mob
QP85R1-21 Resolution Process for Providers Serving Minnesota Health Care Programs (MHCP) Members
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 11, 2022
Tus kws kho mob
Proton Pump Inhibitors (PPI's) - Medicaid
Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2024
Tus kws kho mob
Proprotein Convertase Subtilisin/kexin type 9 (PCSK9) Inhibitors - Medicaid - Effective Date 02/01/2025
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Proprotein Convertase Subtilisin/kexin type 9 (PCSK9) Inhibitors - Commercial - Effective Date 02/01/2025
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 01, 2025